Status:
NOT_YET_RECRUITING
Evaluation of Cognitive Dysfunction and Psychiatric Comorbidities
Lead Sponsor:
Assiut University
Conditions:
Wilson Disease
Eligibility:
All Genders
8-70 years
Brief Summary
Primary objective * Collection of patients with wilson disease either presented with neurological or hepatic symptoms * Assessment of psychiatric and cognitive disorders in both groups by using speci...
Detailed Description
Wilson's disease is an autosomal recessive disorder of copper metabolism caused by ATP7B mutations. Originally described as hepatolenticular degeneration, it classically presents with the combination ...
Eligibility Criteria
Inclusion
- age 8-70, both sexes, diagnosed as Wilson disease.
Exclusion
- • Patients with neurological symptoms due to neurological disease other than Wilson disease such as patients with cerebrovascular stroke or Parkinson disease, ……
- Patients with hepatic encephalopathy or severe neurological impairments (disabling dysarthria, tremor or dystonia) or severe psychiatric disorders incompatible with neuropsychological examination
- Patients with liver transplant
Key Trial Info
Start Date :
December 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06179394
Start Date
December 15 2023
End Date
March 1 2026
Last Update
December 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.